Select Language:
Dubai is implementing new regulations to curb monopolistic practices in the pharmaceutical industry. Healthcare professionals believe these changes could lead to lower medication costs and fewer drug shortages. The updated rules mandate that pharmaceutical firms appoint multiple authorized agents within the UAE for each product. The aim is to foster competition among distributors and bolster supply chain reliability.
Experts highlight that when one distributor monopolizes a drug, they can manipulate prices with minimal market pushback. Introducing multiple authorized agents is expected to enhance competition, which may gradually reduce costs for consumers. Additionally, reliance on a single supplier has previously caused shortages during production delays or international disruptions, impacting access to medications for diabetes, weight management, and mental health conditions in recent years.
Having more than one authorized distributor would make it less likely that logistical failures at a single company would disrupt patient care. It’s also anticipated that increased competition will elevate standards in storage and transportation services.
ChatGPT
Perplexity
Gemini AI
Grok AI
